A carregar...
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation
Pharmacologic augmentation of endogenous cannabinoid (eCB) signaling is an emerging therapeutic approach for the treatment of a broad range of pathophysiological conditions. Thus far, pharmacological approaches have focused on inhibition of canonical eCB inactivation pathways, fatty acid amide hydro...
Na minha lista:
Main Authors: | , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4074568/ https://ncbi.nlm.nih.gov/pubmed/24845457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2014.04.006 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|